Orion Investment Company’s Blueprint Medicines BPMC Stock Holding History

Orion Investment Company’s Portfolio BPMC Stock Details BPMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-106,134	Closed	-$13.6M	–	71
2025 Q2	$13.6M	Sell	106,134 -2,899	-3%	-$301K	4.82%	5
2025 Q1	$9.65M	Buy	109,033 +363	+0.3%	+$35.4K	3.95%	7
2024 Q4	$9.48M	Buy	108,670 +60	+0.1%	+$5.5K	3.78%	6
2024 Q3	$10M	Sell	108,610 -180	-0.2%	-$17.9K	3.91%	5
2024 Q2	$11.7M	Buy	+108,790	New	+$10.9M	4.67%	4

Other funds holding BPMC

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Orion Investment Company's BPMC Position: Q3 2025 in Review

Orion Investment Company sold out of Blueprint Medicines (BPMC) in Q3 2025, closing a stake of 106,134 shares — an estimated $13.6M sold.

Orion Investment Company first reported a position in BPMC in Q2 2024 and held it in 5 quarters. The position peaked at $13.6M in Q2 2025. 5 funds tracked by Wall St. Rank hold BPMC as of Q3 2025.

Orion Investment Company reported no remaining Blueprint Medicines position as of Q3 2025 after selling out during the quarter.
Orion Investment Company sold 106,134 Blueprint Medicines shares in Q3 2025, an estimated $13.6M.
Orion Investment Company first reported a position in Blueprint Medicines in Q2 2024 and held it in 5 quarters.
Orion Investment Company's Blueprint Medicines position peaked at $13.6M in Q2 2025.
5 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2025.

Based on Orion Investment Company's 13F filing for Q3 2025, filed 13 Nov 2025.